Cells are incredibly dense molecular environments. When a small molecule drug or natural product enters a cell, it encounters thousands of proteins simultaneously. Pinpointing exactly which proteins it binds to—its "interactome"—is one of the hardest challenges in drug discovery. Traditional biochemical assays often require disrupting the cell membrane, which destroys the native context and causes transient or low-affinity interactions to be lost.
To solve this, modern chemical biology combines chemical proteomics and bioorthogonal chemistry. The core intuition is to equip a molecule of interest with a tiny, chemically inert handle that can pass into living cells unnoticed. Once inside, the molecule binds its target in its native environment. Researchers can then trigger a permanent covalent bond between the molecule and its target, and use highly selective "click" chemistry to attach a molecular hook (like biotin) to pull the complex out of the cellular soup for identification via mass spectrometry.
Covalent Capture: Freezing Transient Interactions
How do we ensure a small molecule stays attached to its target during the harsh process of cell lysis and purification? The answer lies in covalent cross-linking, which permanently anchors the probe to its binding partner.
One major strategy is Activity-Based Protein Profiling (ABPP). As reviewed by Yongping Zhu et al. in their work on celastrol targets, ABPP uses chemical probes that structurally mimic a small molecule or substrate but contain a reactive "warhead." This warhead targets active-site residues (such as cysteines), permanently bonding the probe to functional enzymes within the native cellular environment. As discussed by Hongru Tao et al., combining ABPP with proximity labeling techniques allows for the capture of transient or low-affinity enzyme-substrate interactions within native environments. This approach is highly effective for profiling entire enzyme classes, such as the broad-spectrum kinome profiling demonstrated by Carmen Oi Ning Leung et al. to identify drivers of drug resistance.
When a small molecule lacks an inherently reactive group, researchers turn to photoaffinity labeling (PAL). Here, the probe is engineered with a photo-reactive group (such as a diazirine or azide) that remains completely inert until exposed to a specific wavelength of UV light. As shown in the validation of PDE6D-RAS inhibitors by Sara Canovas Nunes et al. and the study of calcium signaling by Wing-Cheung Chan et al., UV irradiation generates a highly reactive, short-lived intermediate. This intermediate instantly inserts into nearby chemical bonds before the molecule can diffuse away, permanently cross-linking the probe to its direct binding partner.
[Small Molecule Probe] ---Binds reversibly---> [Target Protein]
|
(UV Light)
v
[Covalent Cross-link] ---Freezes complex---> [Stable Conjugate]
Bioorthogonal Click Chemistry: The Invisible Handle
A covalent bond freezes the interaction, but isolating the tagged protein from millions of unmodified molecules requires a reporter tag, like biotin or a fluorophore. However, attaching a bulky dye directly to a drug often ruins its cell permeability or prevents it from fitting into the protein's binding pocket.
The solution is to split the process into two steps using bioorthogonal chemistry—chemical reactions that can occur inside living systems without interfering with native biological processes. Probes are synthesized with miniature handles, typically an alkyne or an azide group. Because these functional groups do not exist in biology, they are completely invisible to the cell.
After the probe has bound and cross-linked to its target inside live cells, researchers introduce a complementary partner tag. Through copper-free click chemistry, such as strain-promoted azide-alkyne cycloaddition (SPAAC), the alkyne and azide snap together rapidly and selectively.
As highlighted by Qi Xue et al. in the construction of antibody-drug conjugates and by Liu Zang et al. in developing self-assembled PROTACs, avoiding copper catalysts prevents heavy-metal toxicity, making this reaction ideal for living systems. This two-step labeling workflow enables high-sensitivity capture and visualization, a principle leveraged by Haijun Guo et al. and Teresa Marker et al. to map the proteome-wide targets of small molecules.
Metabolic Labeling: Tracking Dynamic Cellular Processes
This chemical toolkit extends beyond tracking synthetic drugs; it can also monitor endogenous cellular dynamics, such as protein synthesis and post-translational modifications (PTMs).
In metabolic labeling, cells are fed synthetic analogs of natural biomolecules that contain bioorthogonal handles. The cell's own enzymatic machinery mistakes these analogs for natural building blocks and incorporates them into biomolecules. For example, Sabyasachi Baboo et al. utilized non-canonical amino acid analogs to intercept the translation machinery, incorporating chemical handles directly into newly synthesized peptide chains to track rapid protein turnover across the nucleus and cytoplasm.
Similarly, A. Emilia Arguello et al. used synthetic nucleoside analogs as mechanism-based suicide substrates to covalently capture RNA-modifying enzymes during catalysis. This strategy is equally powerful for mapping lipid modifications like myristoylation or palmitoylation, where bioorthogonal probes attach detectable markers to specific lipid structures without disrupting natural cellular functions, as described by Feifei Li et al..
Mass Spectrometry and Proteomic Deconvolution
Once the target proteins are covalently tagged and bioorthogonally linked to an affinity handle (like biotin), they are isolated via streptavidin-coated beads. The final step is identifying these isolated proteins using quantitative mass spectrometry.
By comparing the abundance of proteins captured by an active probe versus a negative control or a competitive inhibitor, researchers can filter out non-specific background binders. Yu Ding et al. demonstrated how combining affinity purification with mass spectrometry and site-directed mutagenesis allows for the precise mapping of covalent binding sites on specific cysteine residues. Furthermore, shotgun proteomics can map entire cellular landscapes, such as the p300-regulated acetylome profiled by Jie Yin et al. to discover downstream enzymatic effectors.
Modular Engineering and Next-Generation Probes
The field continues to evolve toward highly modular and high-speed conjugation strategies that minimize disruption to the underlying biology. To minimize functional disruption during labeling, sequential strategies can be deployed to attach donor and acceptor pairs to proteins of interest, as explored by David M. Wu for assessing molecular integrity.
For faster kinetics, Francesco Terzani et al. introduced an oxalyl thioester-mediated chemoselective ligation protocol that enables exceptionally fast site-specific protein modification even at low nanomolar concentrations where traditional methods typically fail.
To streamline diagnostics and imaging, researchers are also engineering self-purifying and miniaturized systems. Jing Jia et al. utilized covalent protein capture tags (HaloTag) to pull down antigens directly from crude cell lysates without labor-intensive purification steps. For high-resolution imaging, Xiaomeng Han et al. showed that recombinant engineering of protein probes with enzymatic tags facilitates site-specific attachment of diverse functional groups while maintaining consistent labeling density. Finally, Julian Kompa et al. developed engineered protein tags that bind unmodified fluorescent dyes, leveraging the dyes' inherent cell permeability and bypassing the need for bulky chemical modifications entirely.
Key Foundational Work
Acetylated and Methylated β-Cyclodextrins as Viable Soluble Supports for the Synthesis of Short 2′-Oligodeoxyribo-nucleotides in Solution (2012) — contributed 2 concept elements to this direction.
Resonance energy transfer for assessing the molecular integrity of proteins for local delivery (2004) — contributed 1 concept elements to this direction.